Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114813) titled 'A Multicenter Cross-sectional Survey of Peripheral Neurotoxicity Symptoms in Breast Cancer Patients Undergoing Chemotherapy in Jilin Province' on Dec. 17, 2025.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: The Second Norman Bethune Hospital of Jilin University
Condition:
Breast Cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: Observation group:1000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=298359
Published by HT Digital Content Services with permiss...